Macro Group Pharmaceuticals - Macro Capital
Macro Group Pharmaceuticals - Macro Capital operates in various business sectors.
Macro Group Pharmaceuticals - Macro Capital (MCRO) - Net Assets
Latest net assets as of : EGP- EGP
Based on the latest financial reports, Macro Group Pharmaceuticals - Macro Capital (MCRO) has net assets worth EGP- EGP as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (EGP-) and total liabilities (EGP-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | EGP- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Macro Group Pharmaceuticals - Macro Capital - Net Assets Trend (None–None)
This chart illustrates how Macro Group Pharmaceuticals - Macro Capital's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Macro Group Pharmaceuticals - Macro Capital (None–None)
The table below shows the annual net assets of Macro Group Pharmaceuticals - Macro Capital from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Macro Group Pharmaceuticals - Macro Capital's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Macro Group Pharmaceuticals - Macro Capital Competitors by Market Cap
The table below lists competitors of Macro Group Pharmaceuticals - Macro Capital ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MAY & BAKER NIGERIA PLC
XNSA:MAYBAKER
|
$256.09 |
|
Pacificonline Systems Inc
PSE:LOTO
|
$256.39 |
|
CHINA MERCH. LAND HD -01
F:TNY1
|
$256.68 |
|
Dewan Cement Ltd
KAR:DCL
|
$258.52 |
|
SOON LIAN HOLDINGS
BE:5SN
|
$254.64 |
|
NEO-NEON HLDGS (N2L.SG)
STU:N2L
|
$254.17 |
|
BlackRock Income and Growth Investment Trust plc
LSE:BRIG
|
$254.02 |
|
WKM TERRAIN
BE:WKM
|
$253.78 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Macro Group Pharmaceuticals - Macro Capital's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Macro Group Pharmaceuticals - Macro Capital's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Macro Group Pharmaceuticals - Macro Capital utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Macro Group Pharmaceuticals - Macro Capital's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.